Shin et al., “Phase I/II Clinical Trial of Didemnin B in Non-Small-Cell Lung Cancer: Neuromuscular Toxicity is Dose-Limiting”, Cancer Chemother Pharmacol, 29:145-149, 1991.* |
Morrison, J.D. et al., The synthesis of norsurfactin, a hemolytic, anticoagulant cyclodepsipeptide., Tetrahedron Letters, 1976, No. 21, (pp. 1773-1776). |
Hardy, P.M. et al. Polypeptides. Part XXV, Synthesis of Isariin, J. Chem. Soc. Perkin Trans. I, 1974, No. 7, (pp. 802-808). |
Michael J. Ignatius, et al. “Expression of apolipoprotein E during nerve degeneration and regeneration”, Proc. Natl. Acad. Sci. USA, vol. 83. (pp. 1125-1129), Feb. 1986. |
Nobuhiro Yamada, et al. “Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits”, Proc. Natl. Acad. Sci. USA, vol. 86, Jan. 1989, (pp. 665-669). |
Hitoshi Shimano, et al. “Plasma Lipoprotein Metabolism in Transgenic Mice Overexpressing Apolipoprotein E”, The American Society for Clinical Investigation, Inc., vol. 90, Nov. 1992 (pp. 2084-2091). |